Alvimopan provides additional improvement in outcomes and cost savings in enhanced recovery colorectal surgery

Annals of Surgery

Volumn 264, Issue 1, 2016, Pages 141-146

  Adam, Mohamed Abdelgadir ^a   Lee, Lacey M ^a   Kim, Jina ^a   Shenoi, Mithun ^a   Mallipeddi, Mohan ^a   Aziz, Hamza ^a   Stinnett, Sandra ^b   Sun, Zhifei ^a   Mantyh, Christopher R ^a   Thacker, Julie K M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alvimopan; colorectal surgery; enhanced recovery after surgery; entereg

Indexed keywords

ALVIMOPAN; GASTROINTESTINAL AGENT; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; COHORT ANALYSIS; COLORECTAL SURGERY; CONTROLLED STUDY; COST CONTROL; ELECTIVE SURGERY; FEMALE; HOSPITAL COST; HOSPITALIZATION; HUMAN; ILEOSTOMY; INTESTINE FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROSPECTIVE STUDY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; SINGLE DRUG DOSE; TOTAL COLON RESECTION; URINARY TRACT INFECTION; AGED; BODY MASS; COMPARATIVE STUDY; CONVALESCENCE; COST BENEFIT ANALYSIS; ECONOMICS; ILEUS; LAPAROSCOPY; MIDDLE AGED; RISK FACTOR; UNITED STATES;

ADULT; AGED; BODY MASS INDEX; COLORECTAL SURGERY; COST SAVINGS; COST-BENEFIT ANALYSIS; FEMALE; GASTROINTESTINAL AGENTS; HOSPITAL COSTS; HUMANS; ILEUS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; PIPERIDINES; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RISK FACTORS; UNITED STATES;

EID: 84945260487     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001428     Document Type: Article

References (31)

1. Augestad KM, Delaney CP. Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery, and enhanced recovery pathways. World J Gastroenterol. 2010; 16: 2067-2074
2. Asgeirsson T, El-Badawi KI, Mahmood A, et al. Postoperative ileus: it costs more than you expect. J Am Coll Surg. 2010; 210: 228-231
3. Iyer S, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Manag Care Pharm. 2009; 15: 485-494
4. Delaney CP, Marcello PW, Sonoda T, et al. Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study. Surg Endosc. 2010; 24: 653-661
5. Madbouly KM, Senagore AJ, Delaney CP. Endogenous morphine levels after laparoscopic versus open colectomy. Br J Surg. 2010; 97: 759-764
6. Cali RL, Meade PG, Swanson MS, et al. Effect of Morphine and incision length on bowel function after colectomy. Dis Colon Rectum. 2000; 43: 163-168
7. Varadhan KK, Neal KR, Dejong CH, et al. The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-Analysis of randomized controlled trials. Clin Nutr. 2010; 29: 434-440
8. Larson DW, Lovely JK, Cima RR, et al. Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery. Br J Surg. 2014; 101: 1023-1030
9. Delaney CP, Zutshi M, Senagore AJ, et al. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum. 2003; 46: 851-859
10. Wind J, Polle SW, Fung Kon Jin PH, et al. Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg. 2006; 93: 800-809
11. Gouvas N, Tan E, Windsor A, et al. Fast-Track vs standard care in colorectal surgery: a meta-Analysis update. Int J Colorectal Dis. 2009; 24: 1119-1131
12. Greco M, Capretti G, Beretta L, et al. Enhanced recovery program in colorectal surgery: a meta-Analysis of randomized controlled trials. World J Surg. 2014; 38: 1531-1541
13. Miller TE, Thacker JK, White WD, et al. Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol. Anesth Analg. 2014; 118: 1052-1061
14. Ludwig K, Enker WE, Delaney CP, et al. Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. Arch Surg. 2008; 143: 1098-1105
15. Delaney CP, Weese JL, Hyman NH, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu-opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum. 2005; 48: 1114-1125. discussion 1125-1126; author reply 1127-1129
16. Hoffmann H, Kettelhack C. Fast-Track surgery-conditions and challenges in postsurgical treatment: a review of elements of translational research in enhanced recovery after surgery. Eur Surg Res. 2012; 49: 24-34
17. Itawi EA, Savoie LM, Hanna AJ, et al. Alvimopan addition to a standard perioperative recovery pathway. JSLS. 2011; 15: 492-498
18. Obokhare ID, Champagne B, Stein SL, et al. The effect of alvimopan on recovery after laparoscopic segmental colectomy. Dis Colon Rectum. 2011; 54: 743-746
19. Kelley SR, Wolff BG, Lovely JK, et al. Fast-Track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg): which is more cost-effective?. Am Surg. 2013; 79: 630-633
20. Gustafsson UO, Scott MJ, SchwenkW, et al. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS 1) Society recommendations. World J Surg. 2013; 37: 259-284
21. Nygren J, Thacker J, Carli F, et al. Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS 1) Society recommendations. World J Surg. 2013; 37: 285-305
22. National Institute for Health and Care Excellence. Ultrasound-guided catheterisation of the epidural space (2008). Available at: http://www.nice.org.uk/guidance/ipg249/resources/guidance-ultrasoundguided-catheterisation-of-Th e-epidural-space-pdf. Accessed June 9, 2015
23. Noblett SE, Watson DS, Huong H, et al. Pre-operative oral carbohydrate loading in colorectal surgery: a randomized controlled trial. Colorectal Dis. 2006; 8: 563-569
24. Habib AS, White WD, Eubanks S, et al. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth Analg. 2004; 99: 77-81
25. Noblett SE, Snowden CP, Shenton BK, et al. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg. 2006; 93: 1069-1076
26. Wolff BG, Michelassi F, Gerkin TM, et al. Alvimopan, a novel, peripherally acting mu-opioid antagonist: results of a multicenter, randomized, doubleblind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg. 2004; 240: 728-734. discussion 734-725
27. Viscusi ER, Goldstein S, Witkowski T, et al. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc. 2006; 20: 64-70
28. Buchler MW, Seiler CM, Monson JR, et al. Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. Aliment Pharmacol Ther. 2008; 28: 312-325
29. Delaney CP, Craver C, Gibbons MM, et al. Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection. Ann Surg. 2012; 255: 731-738
30. Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg. 2007; 245: 355-363
31. Kang CY, Chaudhry OO, Halabi WJ, et al. Risk factors for postoperative urinary tract infection and urinary retention in patients undergoing surgery for colorectal cancer. Am Surg. 2012; 78: 1100-1104